Most side effects are GI-related, dose-dependent, and temporary. Here's what the clinical data says—and what people actually experience.
Nausea. Vomiting. Constipation. The GI side effects of Ozempic are well-documented, widely discussed online, and—critically—manageable for the majority of people who stick with the medication. The STEP clinical trials showed that about 20% of semaglutide patients discontinued due to adverse events, which means 80% pushed through and stayed on treatment.
What you experience, and when, follows a predictable pattern tied to the titration schedule. Understanding this timeline helps you know what's normal versus what warrants a call to your doctor.
Ozempic is a GLP-1 receptor agonist. GLP-1 (glucagon-like peptide-1) is a hormone your gut produces naturally after eating. Ozempic mimics this hormone at a much higher concentration and for much longer (it has a half-life of about one week, vs. minutes for natural GLP-1).
The mechanisms that make Ozempic effective are also what cause most side effects:
The good news: most people adapt. Tolerance develops over weeks, and side effects typically peak after each dose increase before fading as your body adjusts.
Understanding the dose escalation schedule is key to understanding the side effect timeline. The standard titration:
| Weeks | Dose | Notes |
|---|---|---|
| 1–4 | 0.25mg/week | Initiation dose (sub-therapeutic—just for tolerance) |
| 5–8+ | 0.5mg/week | First therapeutic dose; side effects often peak here |
| Week 9–12+ | 1mg/week | Second increase; another wave of adaptation |
| Week 13+ | 2mg/week | Maximum approved dose; not always reached |
The 0.25mg starting dose is technically sub-therapeutic—its purpose is tolerance building, not efficacy. Most people experience minimal side effects at this dose. You might notice:
Many people feel little to nothing during this phase and wonder if the medication is doing anything. It is—just building up in your system. Injections are given weekly; take them on the same day each week.
The jump to 0.5mg is where most people first notice meaningful GI effects. Clinical trial data shows nausea rates of 20–30% at this stage. Common experiences:
By weeks 9–12 on a stable dose, most people notice GI symptoms have diminished substantially. Nausea may still occur after injection day but is typically mild. Appetite suppression stabilizes—you're not ravenously hungry, but also not unable to eat.
When the dose increases to 1mg (if it does), expect another smaller wave of side effects similar to weeks 5–6, but typically less intense. Your body has learned to adapt.
Most people on a stable maintenance dose (whether 0.5mg, 1mg, or 2mg) report GI symptoms that are predictable and manageable: mild nausea on injection day, then minimal symptoms the rest of the week. Constipation, if present, often becomes the main ongoing complaint—fiber intake and hydration matter here.
The clinical trials offered some guidance, and patient experience adds to it. What actually works:
Ozempic is injected subcutaneously (under the skin) in the abdomen, thigh, or upper arm. Injection site reactions are generally mild:
Always rotate injection sites—don't inject in the same spot twice in a row. Use a new pen needle each time.
Hair thinning and shedding (telogen effluvium) is reported by a meaningful subset of Ozempic and GLP-1 users. This isn't in the official prescribing information as a common adverse event, but it appears consistently in patient reports and some observational studies. The likely mechanism: rapid caloric restriction and significant weight loss trigger the hair cycle into a shedding phase. It typically starts 2–4 months after significant weight loss begins and resolves on its own within 6–12 months. Adequate protein intake (at least 0.8–1g per pound of lean body mass) and not losing weight too rapidly may reduce severity.
Most Ozempic side effects are a nuisance, not a danger. But there are serious risks you need to recognize:
GLP-1 agonists have been associated with acute pancreatitis in rare cases. Warning signs: severe, constant abdominal pain (especially if it radiates to your back), pain that's worse after eating. If you experience this, stop the medication and seek emergency care immediately. Do not restart without medical evaluation.
In patients with pre-existing diabetic retinopathy, rapid improvement in blood sugar control (exactly what Ozempic can cause) can temporarily worsen retinopathy. This is a paradoxical effect seen with rapid glycemic improvement from any cause. If you have documented diabetic retinopathy, your doctor should schedule ophthalmology follow-up before and during Ozempic treatment.
Animal studies showed GLP-1 agonists caused medullary thyroid carcinoma (MTC) in rodents at high doses. This has not been confirmed in humans, but Ozempic carries a black box warning: do not use if you have a personal or family history of MTC, or Multiple Endocrine Neoplasia syndrome type 2 (MEN2). Report any lump or swelling in the neck, difficulty swallowing, or persistent hoarseness to your doctor.
GLP-1 agonists may increase the risk of gallstones and cholecystitis (gallbladder inflammation). The risk appears higher with rapid weight loss. Symptoms to watch for: severe pain in the upper right abdomen, especially after fatty meals, potentially with fever or jaundice.
Social media coined "Ozempic face" to describe facial aging or hollowing seen in some people on GLP-1 medications. This is primarily a consequence of rapid, significant weight loss—not a specific drug effect. When you lose fat quickly throughout your body, including in your face, the skin doesn't have time to contract, leading to a gaunt appearance.
The clinical implication: slower, more controlled weight loss (which may mean not maximizing your dose) can reduce this effect. Resistance training to maintain muscle mass, adequate protein, and hydration also help. For those with significant facial volume loss, injectable fillers are an option—but this is cosmetic, not medical.
Call your prescriber (don't just wait for your next appointment) if you experience:
For most people, Ozempic side effects are front-loaded—worst in the first few months, improving significantly as you adapt. The data supports that the majority of people who get through the initial GI phase experience good tolerability at maintenance doses.
Use our Weight Loss Projection tool to understand what realistic outcomes look like given the side effect profile and typical adherence rates.
Nausea is typically worst in weeks 2–4 after each dose increase and improves significantly by weeks 8–12 at a stable dose. Most people find nausea becomes manageable with dietary adjustments. Persistent severe nausea beyond 3 months at a stable dose is less common and should be discussed with your prescriber.
Hair thinning and shedding is reported by a subset of users, typically starting 2–4 months after significant weight loss begins. The mechanism appears to be rapid caloric restriction triggering telogen effluvium, not a direct drug effect. It usually resolves within 6–12 months. Adequate protein intake and not losing weight too rapidly may help.
Yes, for severe nausea your doctor can prescribe ondansetron (Zofran) or other antiemetics. Over-the-counter options like ginger supplements have modest evidence and are generally safe. Always confirm any new medication with your prescriber or pharmacist, particularly if you take other drugs that Ozempic's delayed gastric emptying could affect.
No. Constipation is a common side effect (8–12% of users) and often the most persistent GI symptom, but it's manageable. Increasing fiber intake, drinking more water, light exercise, and occasional use of osmotic laxatives (like MiraLax) are effective strategies. Discuss persistent constipation with your doctor if lifestyle measures aren't sufficient.
Use our Weight Loss Projection calculator for a personalized estimate based on clinical trial data and your starting weight.
Weight Loss Projection →Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Side effect experiences vary significantly between individuals. Never stop a medication without consulting your prescriber. If you experience severe symptoms, seek medical care immediately. This content is not a substitute for personalized medical evaluation.
Compare Providers
These providers offer online consultations, licensed prescribers, and medication shipped to your door.
GLP-1 specialist. Fast evaluation, compounded semaglutide & tirzepatide, competitive pricing.
Get Started →High patient satisfaction. Compounded semaglutide at lower cost. No in-person visit required.
Get Started →Connects patients with licensed GLP-1 prescribers. Multiple medication options, ongoing support.
Get Started →Compare all GLP-1 providers → • Sponsored links. Medical evaluation required. Results vary. See full provider comparison.